Your browser doesn't support javascript.
loading
Hepatitis C antibody intraassay correlation: is retest in duplicate necessary?
Contreras, Ana M; Tinoco, Erendi; Celis, Alfredo; Novelo, Bárbara; Romero, M V Patricia; Carrada, Etelvina; Jiménez-Méndez, Ricardo.
Afiliação
  • Contreras AM; Health Research Council in Jalisco State, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico. acontreras53@hotmail.com
Transfusion ; 47(9): 1686-90, 2007 Sep.
Article em En | MEDLINE | ID: mdl-17725735
BACKGROUND: The hepatitis C virus antibody (anti-HCV) can be identified with third-generation immunoassays. The purpose of this study was to define the correlation or agreement between first and second reactive results of anti-HCV microparticle-based enzyme immunoassay (MEIA) and of chemiluminescence assays (ChLIAs) in blood donors, to determine whether repeat testing is necessary. STUDY DESIGN AND METHODS: Commercially available assays, third-generation HCV MEIA (Abbott), third-generation HCV ChLIA (Ortho), and third-generation HCV ChLIA (Abbott), were used to evaluate anti-HCV repeatedly reactive blood obtained from donations made at 23 Mexican blood centers over a period of 1 year. The intraassay correlation between first and second reactive anti-HCV tests with the Pearson r test and the coefficient of variation (CV) were determined. RESULTS: The intraassay correlation of 565 anti-HCV repeatedly reactive samples was 0.996 for the Abbott third-generation HCV MEIA, 0.995 for the Ortho third-generation HCV ChLIA, and 0.993 for the Abbott third-generation HCV ChLIA. The CVs of these assay systems were 2.82, 5.33, and 5.69 percent, respectively. CONCLUSION: A highly significant intraassay correlation between anti-HCV duplicates was found. Specimens with a single reactive anti-HCV result with the Abbott third-generation HCV MEIA, Ortho third-generation HCV ChLIA, and Abbott third-generation HCV ChLIA assays should be considered as positive and need not be retested. Such a change in the algorithm for blood donor screening is feasible because of the availability of highly automated platforms.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoensaio / Anticorpos Anti-Hepatite C Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Transfusion Ano de publicação: 2007 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoensaio / Anticorpos Anti-Hepatite C Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Transfusion Ano de publicação: 2007 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos